Endothelial cell cytoprotection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors

European Journal of Immunology

Volumn 33, Issue 11, 2003, Pages 3127-3135

  Delikouras, Alexandros ^a   Fairbanks, Lynette D ^b   Simmonds, Anne H ^b   Lechler, Robert I ^a   Dorling, Anthony ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Adenosine; Antibodies; Endothelial cells; Nitric oxide; Transplantation

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ALLOANTIBODY; CYCLIC AMP; PROTEIN BCL XL; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GRAFT SURVIVAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; SWINE; WESTERN BLOTTING;

ADENOSINE; ANIMALS; ANTIBODIES; BCL-X PROTEIN; CRYOPRESERVATION; ENDOTHELIAL CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ADENOSINE A2; SIGNAL TRANSDUCTION; SWINE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0242559051     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323566     Document Type: Article

References (35)

1. Bach, F. H., Hancock, W. W. and Ferran, C., Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol. Today 1997. 18: 483-486.
2. Balla, A., Toth, B., Timar, G., Bak, J. and Krajcsi, P., Molecular targets for pharmacological cytoprotection. Biochem. Pharmacol. 2001. 61: 769-777.
3. Murry, C. E., Jennings, R. B. and Reimer, A., Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986. 74: 1124-1136.
4. Baxter, G. F., Marber, M. S., Patel, V. C. and Yellon, D. M., Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 1994. 90: 2993-3000.
5. Takano, H., Tang, X. L., Qiu, Y., Guo, Y., French, B. A. and Bolli, R., Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ. Res. 1998. 83: 73-84.
6. Dorling, A., Stocker, C., Tsao, T., Haskard, D. O. and Lechler, R. I., In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and downregulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996. 62: 1127-1136.
7. Dorling, A. and Lechler, R. I., Glaxo/MRS Young Investigator Prize. Xenotransplantation: immune barriers beyond hyperacute rejection. Clin. Sci. (Lond.) 1997. 93: 493-505.
8. Dorling, A., Delikouras, A., Nohadani, A. M., Polak, J. and Lechler, R. I., In vitro accommodation of porcine endothelial cells by low dose human anti-pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production. Xenotransplantation 1998. 5: 84-92.
9. Delikouras, A., Hayes, M., Malde, P., Lechler, R. I. and Dorling, A., Nitric oxide-mediated expression of Bcl-2 and Bcl-xL and protection from TNFα-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 2001. 71: 599-605.
10. Salama, A., Delikouras, A., Pusey, C. D., Cook, H. T., Bhangal, G., Lechler, R. I. and Dorling, A., Transplant accommodation in highly sensitized patients: A potential role for Bcl-xL and alloantibody. Am. J. Transplant. 2001. 1: 260-269.
11. Soares, M. P., Lin, Y., Sato, K., Stuhlmeier, K. M. and Bach, F. H., Accommodation. Immunol Today 1999. 20: 434-437.
12. Olanrewaju, H. A., Qin, W., Feoktistov, I., Scemama, J. L. and Mustafa, S. J., Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2000. 279: H650-H656.
13. Saito, T., Itoh, H., Chun, T. H., Fukunaga, Y., Yamashita, J., Doi, K., Tanaka, T., Inoue, M., Masatsugu, K., Sawada, N., Sakaguchi, S., Arai, H., Mukoyama, M., Tojo, K., Hosoya, T. and Nakao, K., Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2001. 281: H1364-H1371.
14. Badrichani, A. Z., Stroka, D. M., Bilbao, G., Curiel, D. T., Bach, F. H. and Ferran, C., Bcl-2 and Bcl-xL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J. Clin. Invest. 1999. 103: 543-553.
15. Dalmasso, A., He, T. and Benson, B. A., Human IgM xenoreactive natural antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 1996. 3: 54.
16. Dalmasso, A. P., Benson, B. A., Johnson, J. S., Lancto, C. and Abrahamson, M. S., Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a gal alpha(1-3)gal binding lectin: up-regulation of CD59 expression. J. Immunol. 2000. 164: 3764-3773.
17. Feoktistov, I. and Biaggioni, I., Adenosine A2b receptors. Pharmacol. Rev. 1997. 49: 382-402.
18. Durante, W., Christodoulides, N., Cheng, K., Peyton, K. J., Sunahara, R. K. and Schafer, A. I., cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am. J. Physiol. 1997. 273: H317-H323.
19. Boucher, M. J., Duchesne, C., Laine, J., Morisset, J. and Rivard, N., cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. Biochem. Biophys. Res. Commun. 2001. 285: 207-216.
20. Feoktistov, I., Ryzhov, S., Goldstein, A. E. and Biaggioni, I., Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ. Res. 2003. 92: 485-492.
21. Sexl, V., Mancusi, G., Holler, C., Gloria-Maercker, E., Schutz, W. and Freissmuth, M., Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 1997. 272: 5792-5799.
22. Cooke, S. P., Hederer, R. A., Pearson, J. D. and Savage, C. O. S., Characterization of human IgG-binding xenoantigens expressed by porcine aortic endothelial cells. Transplantation 1995. 60: 1274-1284.
23. Azimzadeh, A., Wolf, P., Thibaudeau, K., Cinqualbre, J., Soulillou, J. P. and Anegon, I., Comparative study of target antigens for primate xenoreactive natural antibodies in pig and rat endothelial cells. Transplantation 1997. 64: 1166-1174.
24. Holzknecht, Z. E., Coombes, S., Blocher, B. A., Lau, C. L., Davis, R. D. and Platt, J. L., Identification of antigens on porcine pulmonary microvascular endothelial cells recognized by human xenoreactive natural antibodies. Lab. Invest. 1999. 79: 763-773.
25. Barrington, W. W., Jacobson, K. A. and Stiles, G. L., Glycoprotein nature of the A2-adenosine receptor binding subunit. Mol. Pharmacol. 1990. 38: 177-183.
26. Ramsoondar, J. J., Machaty, Z., Costa, C., Williams, B. L., Fodor, W. L. and Bondioli, K. R., Production of alpha 1,3-galactosyltransferase-knockout cloned pigs expressing human alpha 1,2-fucosylosyltransferase. Biol. Reprod. 2003. 69: 437-445.
27. Bouma, M. G., Van Den Wildenberg, F. and Buurman, W. A., Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 1997. 270: C522-C529.
28. Cain, B. S., Meldrum, D. R., Dinarello, C. A., Meng, X., Banerjee, A. and Harken, A. H., Adenosine reduces cardiac TNF-alpha production and human myocardial injury following ischemia reperfusion. J. Surg. Res. 1998. 76: 117-123.
29. Yao, Y., Sei Y., Abbracchio, M. P., Jiang, J. L., Kim, Y. C. and Jacobson, K. A., Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists. Biochem. Biophys. Res. Commun. 1997. 232: 317-322.
30. Liu, J., Tian, Z., Gao, B. and Kunos, G., Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells. Differential involvement of adenosine. J. Biol. Chem. 2002. 277: 20927-20933.
31. Morandini, R., Ghanem, G., Portier, L. A., Robaye, B., Renaud, A. and Boeynaems, J. M., Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am. J. Physiol. 1996. 270: H807-H816.
32. Li, J. M., Fenton, R. A., Cutler, B. S. and Dobson, J. G., Adenosine enhances nitric oxide production by vascular endothelial cells. Am. J. Physiol. 1995. 269: C519-C523.
33. Zhao, Z. Q., Budde, J. M., Morris, C., Wang, N. P., Velez, D. A., Muraki, S., Guyton, R. A. and Vinten J. J., Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J. Mol. Cell. Cardiol. 2001. 33: 57-68.
34. Sachs, D. H., Leight, G., Cone, J., Schwarz, S., Stuart, L. and Rosenberg, S., Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976. 22: 559-567.
35. Fairbanks, L. D., Carrey, E. A., Ruckemann, K., Swaminathan, R., Kirschbaum, B. and Simmonds, H. A., Simultaneous separation by high-performance liquid chromatography of carbamoyl aspartate, carbamoyl phosphate and dihydroorotic acid. J. Chromatogr. B Biomed. Sci. Appl. 1999. 732: 487-93.